Twitter

Non-selective Beta Blockers Versus EVL for Primary Prophylaxis of Esophageal Variceal Bleeding in Patients With Hepatocellular Carcinoma With Portal Vein Tumour Thrombosis.

Condition:   Hepatocellular Carcinoma With Portal Vein Thrombosis
Interventions:   Procedure: Endoscopic Variceal Ligation;   Drug: Carvedilol
Sponsors:   Institute of Liver and Biliary Sciences, India;   Institute of Liver and Biliary Sciences, India
Not yet recruiting – verified August 2012

Here is the original post: Non-selective Beta Blockers Versus EVL for Primary Prophylaxis of Esophageal Variceal Bleeding in Patients With Hepatocellular Carcinoma With Portal Vein Tumour Thrombosis.




Comments are closed.